Klobuchar Statement on Weight Loss Drug Pricing Announcement
November 06, 2025
November 06, 2025
WASHINGTON, Nov. 6 -- Sen. Amy Klobuchar, D-Minnesota, issued the following news release:
* * *
Klobuchar Statement on Weight Loss Drug Pricing Announcement
*
WASHINGTON - Today, U.S. Senators Amy Klobuchar (D-MN) released the following statement in response to Eli Lilly and Novo Nordisk's newly negotiated prices for weight loss drugs for Medicare beneficiaries.
"Today's announcement of lower prices for Ozempic and . . .
* * *
Klobuchar Statement on Weight Loss Drug Pricing Announcement
*
WASHINGTON - Today, U.S. Senators Amy Klobuchar (D-MN) released the following statement in response to Eli Lilly and Novo Nordisk's newly negotiated prices for weight loss drugs for Medicare beneficiaries.
"Today's announcement of lower prices for Ozempic and . . .
